Comment on Bezin et al. GLP-1 Receptor Agonists and the Risk of Thyroid Cancer. Diabetes Care 2023;46:384-390.

التفاصيل البيبلوغرافية
العنوان:	Comment on Bezin et al. GLP-1 Receptor Agonists and the Risk of Thyroid Cancer. Diabetes Care 2023;46:384-390.
المؤلفون:	Endo M; Division of Metabolism, Endocrinology, and Nutrition, University of Washington, Seattle, WA., Roth MY; Division of Metabolism, Endocrinology, and Nutrition, University of Washington, Seattle, WA., Tylee TS; Division of Metabolism, Endocrinology, and Nutrition, University of Washington, Seattle, WA., DeSantis A; Division of Metabolism, Endocrinology, and Nutrition, University of Washington, Seattle, WA., Hirsch IB; Division of Metabolism, Endocrinology, and Nutrition, University of Washington, Seattle, WA.
المصدر:	Diabetes care [Diabetes Care] 2023 May 01; Vol. 46 (5), pp. e118.
نوع المنشور:	Letter; Comment
اللغة:	English
بيانات الدورية:	Publisher: American Diabetes Association Country of Publication: United States NLM ID: 7805975 Publication Model: Print Cited Medium: Internet ISSN: 1935-5548 (Electronic) Linking ISSN: 01495992 NLM ISO Abbreviation: Diabetes Care Subsets: MEDLINE
أسماء مطبوعة:	Publication: Alexandria Va : American Diabetes Association Original Publication: New York, American Diabetes Assn.
مواضيع طبية MeSH:	Thyroid Neoplasms/epidemiology , Diabetes Mellitus/drug therapy , Diabetes Mellitus*/epidemiology, Humans ; Glucagon-Like Peptide-1 Receptor/agonists ; Hypoglycemic Agents
التعليقات:	Comment on: Diabetes Care. 2023 Feb 1;46(2):384-390. (PMID: 36356111) Comment in: Diabetes Care. 2023 May 1;46(5):e121-e122. (PMID: 37185689)
المشرفين على المادة:	0 (Glucagon-Like Peptide-1 Receptor) 0 (Hypoglycemic Agents)
تواريخ الأحداث:	Date Created: 20230515 Date Completed: 20230517 Latest Revision: 20230521
رمز التحديث:	20230521
DOI:	10.2337/dc22-2454
PMID:	37185687
قاعدة البيانات:	MEDLINE

الوصف
تدمد:	1935-5548
DOI:	10.2337/dc22-2454